NCT01290757View on ClinicalTrials.gov

Bioequivalence of Two Different Capsule Types of Dabigatran

PHASE1CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

April 30, 2011

Conditions
Healthy
Interventions
DRUG

Dabigatran etexilate

150 mg Capsugel (T)

DRUG

Dabigatran etexilate

150 mg Qualicaps (R)

Trial Locations (1)

Unknown

1160.117.1 Boehringer Ingelheim Investigational Site, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY